F.D. Roosvelt university hospital
Banská Bystrica, Slovakia
NCT Number: NCT07439913
The aim of the present project is to evaluate long-term oncological and functional treatment outcomes, as well as patient satisfaction, ten years after radical prostatectomy in patients initially enrolled in CPRRP study. This research builds on a previous five-year follow-up evaluation (approved by the ethics committee) and focuses on the durability of therapeutic effects, quality of life, and long-term complications. Data will be collected via telephone interviews assessing key parameters (PSA levels, information on subsequent radiotherapy and androgen-deprivation therapy, the ICIQ-SF and IIEF-5 questionnaires, and patient-reported quality-of-life and satisfaction measures), followed by statistical analysis.
Interested in participating?
Request InfoMale
Observational
Banská Bystrica, Slovakia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Robot assisted radical prostatectomy
Time frame: From treatment to 10 years.
Prostate cancer biochemical recurrence rate
Time frame: From surgery until 10 years.
Postprostatectomy incontinence
Time frame: From surgery until 10 years.
Postprostatectomy erectile dysfunction rate
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
Other
Ten-Year Oncologic and Functional Results of Prostate Cancer Treatment by Radical Prostatectomy and the Rate of Patient Satisfaction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07693647
Adenocarcinoma, Carcinoma
Valencia, Spain
View Trial DetailsNCT06834204
Adenocarcinoma, Bladder Cancer
New Brunswick, New Jersey, United States
View Trial DetailsNCT06872619
Adenocarcinoma, Androgen Deprivation Therapy
Münster, Germany
View Trial DetailsNCT06865547
Adenocarcinoma, Carcinoma
Guangzhou, Guangdong, China
View Trial Details